Dr. James Polli’s extraordinary accomplishments in the field of regulatory science make him a UMB Champion of Excellence.

Third-year student pharmacists take the gold for their proposal to develop a transparent tracking system for emerging CAR T-cell gene therapies.

Graduates and current students in the PhD in Pharmaceutical Sciences and MS in Regulatory Science programs enjoy day-long networking and professional development event.

First-ever undergraduate competitor takes the gold for project to develop a universal labeling system for hazardous drugs.

Researchers across academia, government, and industry explore how real world evidence can be harnessed to create a national evaluation system and improve the safety and effectiveness of medical devices.

Fourth annual M-CERSI “America’s Got Regulatory Science Talent” competition awards third-year student pharmacists first prize for novel solution to improve FDA’s post-marketing surveillance program.

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.

Researchers from academia, government, and industry examine benefits and new methods associated with emerging technology.

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

Researchers from academia, government, and industry discuss how increasingly large, complex datasets can be harnessed to improve the drug development process.